About DILIsym
DILIsym is a company based in Durham (United States) founded in 2014 was acquired by Simulations Plus in May 2017.. DILIsym operates in a competitive market with competitors including Insitro, HotSpot Therapeutics, TOLREMO therapeutics, Certara and Inpharmatica, among others.
- Headquarter Durham, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$1.5 M (USD), Grant
Jan 17, 2019
-
Investors
Simulations Plus
& 1 more
-
Employee Count
Employee Count
-
Acquired by
Simulations Plus
(May 01, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of DILIsym
- Total Funding Total Funding
- Total Rounds 1
- Last Round Grant — $1.5M
-
First Round
First Round
(17 Jan 2019)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2019 | Amount | Grant - DILIsym | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in DILIsym
DILIsym has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Simulations Plus and National Institute of Diabetes and Digestive and Kidney Diseases. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Research and health information on diabetes and kidney diseases are provided by NIDDK.
|
Founded Year | Domain | Location | |
|
Simulation software is developed for chemoinformatics and drug discovery.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by DILIsym
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - DILIsym
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Dilisym Comparisons
Competitors of DILIsym
DILIsym operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, HotSpot Therapeutics, TOLREMO therapeutics, Certara and Inpharmatica, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Developer of a platform for protein function analysis
|
|
| domain | founded_year | HQ Location |
Anti-cancer small molecules are developed to target drug resistance pathways.
|
|
| domain | founded_year | HQ Location |
Provider of a platform for in silico drug discovery and consulting services
|
|
| domain | founded_year | HQ Location |
Developer of predictive informatics based platform for drug discovery
|
|
| domain | founded_year | HQ Location |
Immune system-based drugs are discovered via biological data analytics.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Dilisym
Frequently Asked Questions about DILIsym
When was DILIsym founded?
DILIsym was founded in 2014 and raised its 1st funding round 5 years after it was founded.
Where is DILIsym located?
DILIsym is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Who is the current CEO of DILIsym?
Brett Howell is the current CEO of DILIsym.
What does DILIsym do?
Founded in 2014 and based in Durham, United States, DILIsym operates in the pharmaceutical software sector. Quantitative toxicology tools are offered to model drug-induced liver injuries and predict patient-specific toxicities. Hazards from individual drug molecules are analyzed through an in silico graphical interface, supporting investigations into compounds, doses, and durations. Integration with the companys SimPops platform enables simulation of inter-individual variability in drug responses across virtual patient populations.
Who are the top competitors of DILIsym?
DILIsym's top competitors include Insitro, HotSpot Therapeutics and Certara.
Who are DILIsym's investors?
DILIsym has 2 investors. Key investors include Simulations Plus, and National Institute of Diabetes and Digestive and Kidney Diseases.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.